Pancreatic Surgery - Optimal Caseload Thresholds and Predictive Accuracy
NCT ID: NCT06389890
Last Updated: 2024-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80000 participants
OBSERVATIONAL
2010-01-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Total Pancreatectomies in Germany - Epidemiology, Trends,
NCT06466928
The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy
NCT07182136
Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver
NCT01474694
Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC
NCT01236989
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
NCT04499833
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Can specific intervention case numbers be identified that are suitable as thresholds for annual minimum volumes and are associated with significantly low hospital mortality?
* Almost all previous studies on case number effects have only shown a descriptive association between the number of cases in a given year and the quality of outcomes in the same year. The aim of this study is to investigate whether the correlations described can be demonstrated when using the previous year's procedure volume as a predictor. The study seeks to answer whether the procedure caseload has predictive value, specifically the number of cases in one year and in-hospital mortality in the following year.
Background:
Numerous studies have demonstrated a correlation between the number of cases and the quality of outcomes for various surgical procedures. For instance, patients who underwent surgery in high-volume hospitals (HVH) had lower mortality rates, longer survival rates, lower complication rates, and lower reoperation rates than patients who underwent surgery in low-volume hospitals (LVH). To subdivide into HVHs and LVHs, either concrete case numbers or quartile or quintile limits with an equal number of operations or clinics per group wer used. The aim of the study is to objectively determine these limits using a spline-modeled caseload term, avoiding arbitrary decisions.
One limitation of the previous findings is that they may not be generalisable due to the use of a limited number of cases and outcome quality from the same year. However, it is important to note that the volume from the previous year is crucial in determining the predictive importance of caseload for future outcome quality. A recent study (in press) reported, that there are significant fluctuations in the quality of outcomes among HVHs, even between different years. Therefore, it was hypothesized that using the number of cases as a predictor of high-quality outcomes may lead to overestimation.
Methods:
The nationwide hospital billing data for Germany (DRG statistics) for the period 2010 to 2019 will be analysed. The risk-adjusted mortality rates are determined. For this purpose, logistic regression models are calculated that adjust the mortality risk for the following variables Sex, age, emergency of admission, year of resection, diagnosis (malign neoplasm vs. benign neoplasm vs. neoplasm of unclear dignity vs. acute pancreatitis vs. chronic pancreatitis vs. other pancreatic diseases), additional procedures (venous resections/ multivisceral resections/ arterial resections/ splenectomy/ cholecystectomy/ biliary drainage/ dialysis procedures) and selected comorbidities. To classify additional procedures in order to reflect extent of surgery and technical difficulty, a slight modification of the classification system as described in Mihaljevic et al, 2021 will be used (PMID: 33386130). The Elixhauser definitions are used for the comorbidities as described in Quan et al, 2005 (PMID: 16224307). The selection of comorbidities to be considered is based on the publication by Hunger et al, 2022 (PMID: 35525416).
The case number effect is modelled using natural cubic splines. The 10th, 20th, 40th, 60th, 80th and 90th case number percentiles are used as node points. The adjusted hospital mortality as a function of the number of cases is determined using Estimated Marginal Means. Local extremes (maxima and minima) in the splines are determined using 1st and 2nd graph derivate.
Various regression models are calculated using either the number of cases from the current year of operation or the previous year. The predictive accuracy of the models is determined using the established measures from signal detection theory (AUC, sensitivity, specificity, positive predictive value, negative predictive value). Subgroup analyses for individual resection procedures will be performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All patients undergoing pancreatic surgery
All patients with at least one pancreatic surgery procedure code
Pancreatic resection procedure
Pancreatic resection procedure
Subgroup: Total pancreatectomy
All patients with at least one of the following pancreatic procedure codes (OPS-codes): '55250', '55251', '55252', '5525x', '5525y'
Pancreatic resection procedure
Pancreatic resection procedure
Subgroup: Pancreaticoduodenectomy
All patients with at least one of the following pancreatic procedure codes (OPS-codes): '55241', '55242', '55243'
Pancreatic resection procedure
Pancreatic resection procedure
Subgroup: Segmental resection
All patients with at least one of the following pancreatic procedure code (OPS-codes): '55244'
Pancreatic resection procedure
Pancreatic resection procedure
Subgroup: Distal pancreatectomy
All patients with at least one of the following pancreatic procedure codes (OPS-codes): '55240', '552400', '552401', '552402'
Pancreatic resection procedure
Pancreatic resection procedure
Subgroup: Other partial resections
All patients with at least one of the following pancreatic procedure codes (OPS-codes): '5524x', '5524y'
Pancreatic resection procedure
Pancreatic resection procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pancreatic resection procedure
Pancreatic resection procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* any pancreatic resection procedure
* operated at any German hospital
Exclusion Criteria
* Inpatient admission for organ removal
* no information on sex
* no information on age
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medizinische Hochschule Brandenburg Theodor Fontane
OTHER
Richard Hunger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Hunger
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rene Mantke, MD
Role: STUDY_DIRECTOR
Head of Surgery at University Hospital Brandenburg an der Havel
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PaSuTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.